Most Read
Discover the most frequently read articles from the past month
Malignant psoas syndrome associated with gynecological malignancy: Three case reports and a review of the literature
Shiro Takamatsu, Kosuke Murakami, Hisamitsu Takaya, Takako Tobiume, Hidekatsu Nakai, Ayako Suzuki, Masaki Mandai, Noriomi Matsumura
Pages: 82-86 Published online on: 21 May 2018
A retrospective survey of the last 3 months of life in patients carrying glioblastoma: Clinical treatments and profiles
Romain Rivoirard, Alexis Vallard, Claire Boutet, Alexander Tuan Falk, Clemence Garin, Anissa Adjabi, Delphine Hoarau, Fabien Forest, Marie‑Jeannette Fotso, Chloe Rancoule, Nicolas Magné
Pages: 115-120 Published online on: 02 November 2017
Tumor markers for hepatocellular carcinoma (Review)
Yan-Jie Zhao, Qiang Ju, Guan-Cheng Li
Pages: 593-598 Published online on: 13 May 2013
The role of peroxiredoxins in cancer (Review)
Arianna Nicolussi, Sonia D'inzeo, Carlo Capalbo, Giuseppe Giannini, Anna Coppa
Pages: 139-153 Published online on: 10 January 2017
Cell cycle checkpoint control: The cyclin G1/Mdm2/p53 axis emerges as a strategic target for broad‑spectrum cancer gene therapy - A review of molecular mechanisms for oncologists
Erlinda M. Gordon, Joshua R. Ravicz, Seiya Liu, Sant P. Chawla, Frederick L. Hall
Pages: 115-134 Published online on: 14 June 2018
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)
Julie L. Hentze, Claus K. Høgdall, Estrid V. Høgdall
Pages: 323-330 Published online on: 11 January 2019
Global serum metabolomics profiling of colorectal cancer (Review)
Nurul Azmir Amir Hashim, Sharaniza Ab‑Rahim, Leny Suzana Suddin, Mohd Shahril Ahmad Saman, Musalmah Mazlan
Pages: 3-14 Published online on: 08 May 2019
Complete remission of peritoneal dissemination of colon cancer by alternate‑day S‑1 and oxaliplatin plus bevacizumab treatment and maintenance chemotherapy comprising alternate‑day S‑1 plus bevacizumab: A case report
Nobuhiro Nitori, Ayu Kato, Tomoaki Deguchi, Jumpei Nakadai, Ayako Tada, Makoto Takahashi, Rumiko Umeda, Naoteru Miyata, Mikinori Kataoka, Tomohisa Kadomura, Hajime Higuchi, Hirotoshi Ebinuma, Atsushi Kato, Takashi Hatori, Yoshifumi Ikeda, Masaru Miyazaki
Pages: 270-274 Published online on: 11 December 2018
Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma
Qiandong Zhu, Yunpeng Sun, Qingqing Zhou, Qikuan He, Haixin Qian
Pages: 597-606 Published online on: 27 September 2018
Cardiotoxicity associated with targeted cancer therapies (Review)
Zi Chen, Di Ai
Pages: 675-681 Published online on: 03 March 2016
The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments
Sandhya Iyer, Rambaksh Prajapati, Aarthi Ramesh, Madhura Basavalingegowda, Seema Todur, Shubham Kavishvar, Rajeev Vijaykumar, Radhesyam Naik, Padmaj Kulkarni, Amit D. Bhatt, Vashishth Maniar, Vinayak Maka, Sateesh Chiradoni Thungappa, Manish Singhal, Anantbhushan Ranade, Gowhar Shafi
Pages: 469-475 Published online on: 20 February 2019
Neurokinin‑1 receptor antagonist aprepitant and radiotherapy, a successful combination therapy in a patient with lung cancer: A case report
Miguel Muñoz, Juan Carlos Crespo, José Pedro Crespo, Rafael Coveñas
Pages: 50-54 Published online on: 10 May 2019
Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)
Fengfeng Cai, Manuel Antonio Falar Luis, Xiaoyan Lin, Minghong Wang, Lu Cai, Chunmei Cen, Ewelina Biskup
Pages: 15-23 Published online on: 08 May 2019
Glioma and glioblastoma ‑ how much do we (not) know? (Review)
Ivana Jovčevska, Nina Kočevar, Radovan Komel
Pages: 935-941 Published online on: 26 August 2013
